TY - JOUR
T1 - Clinical and angiographic follow-up after long versus short stenting in unselected chronic coronary occlusions
AU - Choi, Si Wan
AU - Leefricc, Cheol Whan
AU - Hong, Myeong Ki
AU - Lee, Jae Hwan
AU - Kim, Jae Joong
AU - Park, Seong Wook
AU - Park, Seung Jung
PY - 2003/6/1
Y1 - 2003/6/1
N2 - Background: Few data are available on the efficacy of long stenting for lesions in unselected chronic total occlusion (CTO). Hypothesis: The study was undertaken to evaluate the angiographic restenosis and long-term clinical outcomes after long stent implantation in patients with CTO. Methods: Our retrospective analysis includes a consecutive series of stent implantation in 220 patients with CTO. We compared angiographic restenosis, target lesion revascularization, and long-term clinical outcomes of short stenting (<20 mm, Group 1, n = 113) with a concurrent series of long stenting (≥ 20 mm, Group 2, n = 107). Results: Angiographic follow-up was obtained in 174 patients (79.5% of those eligible), and the rates of angiographic restenosis were 19.3% in Group 1 and 33.7% in Group 2 (p<30.05). In multivariate analysis, the postinterventional minimal lumen diameter was the only independent predictor of restenosis (odds ratio = 0.20, 95% confidence interval 0.08-0.49, p<0.01). The angiographic restenosis rate was significantly lower in Group 1 than in Group 2 in patients with final minimal lumen diameter <3.0 mm (28.9 vs. 55.9%, respectively, p<0.05). However, the angiographic restenosis rate was not significantly different between the two groups in patients with final minimal lumen diameter ≥3 mm (12.0 vs. 19.2%, respectively, p = NS). During the follow-up (29.1 ± 10.8 months), there was no difference between the two groups in death, nonfatal myocardial infarction, and target lesion revascularization. Conclusions: The use of long (≥20 mm) versus short (<20 mm) stents in patients with CTO is associated with a higher angiographic restenosis rate, but there is an equivalent risk of restenosis in selected patients with relatively large-sized vessels.
AB - Background: Few data are available on the efficacy of long stenting for lesions in unselected chronic total occlusion (CTO). Hypothesis: The study was undertaken to evaluate the angiographic restenosis and long-term clinical outcomes after long stent implantation in patients with CTO. Methods: Our retrospective analysis includes a consecutive series of stent implantation in 220 patients with CTO. We compared angiographic restenosis, target lesion revascularization, and long-term clinical outcomes of short stenting (<20 mm, Group 1, n = 113) with a concurrent series of long stenting (≥ 20 mm, Group 2, n = 107). Results: Angiographic follow-up was obtained in 174 patients (79.5% of those eligible), and the rates of angiographic restenosis were 19.3% in Group 1 and 33.7% in Group 2 (p<30.05). In multivariate analysis, the postinterventional minimal lumen diameter was the only independent predictor of restenosis (odds ratio = 0.20, 95% confidence interval 0.08-0.49, p<0.01). The angiographic restenosis rate was significantly lower in Group 1 than in Group 2 in patients with final minimal lumen diameter <3.0 mm (28.9 vs. 55.9%, respectively, p<0.05). However, the angiographic restenosis rate was not significantly different between the two groups in patients with final minimal lumen diameter ≥3 mm (12.0 vs. 19.2%, respectively, p = NS). During the follow-up (29.1 ± 10.8 months), there was no difference between the two groups in death, nonfatal myocardial infarction, and target lesion revascularization. Conclusions: The use of long (≥20 mm) versus short (<20 mm) stents in patients with CTO is associated with a higher angiographic restenosis rate, but there is an equivalent risk of restenosis in selected patients with relatively large-sized vessels.
UR - http://www.scopus.com/inward/record.url?scp=0038546826&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038546826&partnerID=8YFLogxK
U2 - 10.1002/clc.4950260605
DO - 10.1002/clc.4950260605
M3 - Article
C2 - 12839043
AN - SCOPUS:0038546826
SN - 0160-9289
VL - 26
SP - 265
EP - 268
JO - Clinical Cardiology
JF - Clinical Cardiology
IS - 6
ER -